Pfizer Names New General Counsel
NEW YORK (Reuters) - Pfizer Inc <PFE.N> on Wednesday named
Amy Schulman, who has led litigation efforts for the drugmaker
involving its painkillers Celebrex and Bextra, as its general
counsel.
Insurances & Business
News Economy Business Investment Banks Credits
Leave a Reply »»
Similar/Related/News:
- Pfizer May Make Counter Bid For Ranbaxy: Report MUMBAI (Reuters) - Pfizer Inc <PFE.N> may bid for Ranbaxy Laboratories Ltd <RANB.BO>, countering a $4.6 billion offer by Japan's Daiic...
- Pfizer Invests $300 Mln in Irish Biotech Facility LONDON (Reuters) - Pfizer Inc <PFE.N>, the world's biggest drugmaker, is to invest 190 million euros ($297 million) establishing a new biote...
- Pfizer Warns of Lung Cancer With Inhaled Insulin NEW YORK (Reuters) - Pfizer Inc <PFE.N> and Nektar Therapeutics <NKTR.O> said on Wednesday clinical trials of the inhaled insulin Exub...
- Movers roundup: Avant, Cypress Semiconductor (AP) Shares of Avant Immunotherapeutics Inc. are climbing after the company licensed a cancer vaccine candidate to drug developer Pfizer....
- Business in the Burbs: Drew Industries names new president CEO Leigh J. Abrams will relinquish his role as president next month as part of the White Plains company's management-succession plan....
- Correction - Fitch Takes Various Rating Actions on 15 AMSI Securitizations (Business Wire) NEW YORK----This is a correction for a message issued on April 16, 2008. It corrects the class names in series 2002-D....
- India’s Ranbaxy Falls Nearly 7 Percent After Lipitor Deal NEW DELHI (Reuters) - Shares in Indian drugmaker Ranbaxy Laboratories Ltd <RANB.BO> fell nearly 7 percent on Thursday morning, after a paten...
- Harvard Names Mendillo as New Investment Chief BOSTON (Reuters) - Harvard University named Jane Mendillo, who built her resume in the endowment world, to oversee the school's $35 billion portfo...